Strathspey Crown purchases Evolus for undisclosed amount

Strathspey Crown acquired Evolus, giving its subsidiary Alphaeon Corporation the exclusive license to market the neurotoxin developed by Daewoon Pharmaceutical.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics